Stellar Biotechnologies Presents Preclinical Poster on Clostridium Difficile Active Immunotherapy at Vaccine Congress
October 28, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Oct 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today the presentation of a preclinical...
Stellar Biotechnologies Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study
October 21, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Oct 21, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today presentation of positive results from...
22157.jpg
Therapeutic Drug Monitoring to Spike to $2.69 Billion by 2019
September 26, 2013 11:24 ET | Research and Markets
Dublin, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/c2g9n5/therapeutic_drug) has announced the addition of the "Therapeutic Drug...
Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors
September 25, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 25, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is very pleased to announce the appointment of Tessie...
Stellar Biotechnologies Closes US$12 Million Private Placement Financing
September 23, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 23, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today, further to its news releases of...
Stellar Biotechnologies Raises US$10 Million in Initial Closing of Private Placement
September 10, 2013 14:59 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 10, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that, further to its news release of...
Stellar Biotechnologies to Present at Rodman and Renshaw 13th Annual Global Investment Conference From September 8-10, 2013
August 29, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 29, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that it will present at the Rodman and...
Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement
August 22, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 22, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announces its intent to close a private placement of up...
Stellar Biotechnologies Issues President's Letter to Shareholders
August 06, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 6, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is pleased to announce that it has issued a letter from...
Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology
July 30, 2013 09:05 ET | Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jul 30, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that the Company has acquired the...